WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2023

May 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2023-05-01

Reporting Person: Favorite Annette F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-01	Common Stock	M	13012.00	$59.64	Acquired	27888.9617	Direct
2023-05-01	Common Stock	S	9425.00	$365.4683	Disposed	18463.9617	Direct
2023-05-01	Common Stock	S	2687.00	$366.4632	Disposed	15776.9617	Direct
2023-05-01	Common Stock	S	900.00	$367.4527	Disposed	14876.9617	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-01	Stock Option (Right to Buy)	$59.64	M	13012.00	Disposed	2026-02-23	Common Stock (13012.00)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $365.00 USD to $365.97 USD; the price reported above reflects the weighted average sale price.

F2: This transaction was executed in multiple trades at prices ranging from $366.01 USD to $366.985 USD; the price reported above reflects the weighted average sale price.

F3: This transaction was executed in multiple trades at prices ranging from $367.03 USD to $367.98 USD; the price reported above reflects the weighted average sale price.